Ionpath provides multiplexed tissue imaging technology for quantitative spatial phenotype mapping of the tissue microenvironment, enabling analysis of disease states and patient responses.

Ionpath

Domain Not Resolving

HSTS

DNSSEC

Cloudflare CDN

IPv6

Cloudflare Hosting

Cloudflare

U.S. Server Location

jsDelivr

Cloudflare JS

Chief Technology Officer

Stuart Friedman

Senior Vice President, Marketing and Corporate Strategy

Brad Nelson

VP of Sales

Daniel Clutter

VP of Pathology

Jessica Finn

Vice President Finance

John Hu

Vice President of Manufacturing Operations

Larry Stevens

Director of Software Engineering

Alex Strigelskiy

Director of Sales, West and South America

Alex Vila

Operations

Danielle Lyons

Director of Product Development

Jay Tarolli

Vikram Chaudhery

Harris Fienberg

Mike Dybbs

Mike Angelo

Co-Founders

Sander Gubbens

Senior Vice President, Marketing & Corporate Strategy

Paul Davy

Director Of Field Service

Goran Pljevaljcic

Chief Commercial Officer

Health Care Companies With Less Than $1M in Revenue (Top 10K)

Biotechnology Companies With Less Than $10M in Revenue (Top 10K)

Health Diagnostics Companies With Fewer Than 50 Employees (Top 10K)

California Companies With Less Than $500M in Revenue (Top 10K)

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Thermo Fisher Scientific

Corporate Round - Ionpath

Genoa Ventures

Samsara BioCapital

Series B - Ionpath

Series A - Ionpath

Seed Round - Ionpath

Menlo Park

California

United States

North America

New Products Posted to GenomeWeb: Bruker, CS Genetics, Ionpath, Evobyte, Parse Biosciences

Ionpath Announces the Launch of MIBIscope™ 3.0 Spatial Proteomics Imaging Platform

Ionpath Launches MIBIplus and MIBIsight, A New Service Offering and User-Friendly Bioinformatics Tools, at SITC 2023

Ionpath Names Goran Pljevaljcic as Chief Commercial Officer

Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation

Fluidigm Appeal in IonPath Patent Infringement Battle Voluntarily Dismissed

Fluidigm Loses Patent Suit Against IonPath

Ionpath Expanding Sales Force, Investing in Informatics Tools Development

A system for highly multiplexed tissue imaging and analysis, including robust instrumentation, validated reagents, and visualization software.

Services for MIBI-enabled phenotype mapping and insight generation, offering quantitative cell segmentation, classification, and spatial analysis.

Technology enabling high-definition spatial proteomics for analysis of tissue microenvironments, capable of imaging 40+ protein markers in a single scan.

A single-cell spatial proteomic solution that detects more than 50 phenotypes in a single scan, with customizable reports and a user-friendly analysis tool.

A selection of primary antibodies pre-conjugated to elemental mass reporters for use in MIBI-based tissue imaging, rigorously tested and validated for optimal performance.

India

Asia

Germany

Europe

Wordpress

Google Analytics

Vimeo

HubSpot Marketing Hub

HubSpot Forms

Google Fonts

Wistia

F5 NGINX

Google Tag Manager

Bootstrap

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 16, 2024 4:03 AM	6f1191fe
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 16, 2024 4:03 AM	b6364bc8
crunchbase trigger	general	Dec 4, 2024 8:54 AM	4e77dc2c
crunchbase profile	general	Dec 4, 2024 2:22 PM	c9ce79b4
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 3:03 PM	f70af2c9
peers	general	Oct 16, 2024 4:03 AM	c9a47377
news basic	general	Oct 16, 2024 4:03 AM	3612fc71
bundesanzeiger	filings
financials download nd	financials
private financials	financials

IONP

COM:IONPATH

Ionpath